
Sign up to save your podcasts
Or
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
4.6
162162 ratings
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
129 Listeners
316 Listeners
849 Listeners
481 Listeners
686 Listeners
282 Listeners
256 Listeners
3,337 Listeners
18 Listeners
18 Listeners
14 Listeners
24 Listeners
90 Listeners
1,093 Listeners
28 Listeners
179 Listeners
509 Listeners
320 Listeners
243 Listeners
18 Listeners
362 Listeners